No Data
No Data
Hong Kong Stock Exchange Announcement | Legendholding expects pre-tax profit of approximately 28 billion to 33 billion yuan in the first half of the year, with overall finances, business, and operations remaining stable.
Baiyunshan's wholly-owned subsidiary plans to invest in the construction of Tianhua Park project, with a total investment of approximately 3.201 billion yuan...
China International Capital Corporation: Peptide production ushers in the opportunities of the times with the rapid expansion of GLP-1.
In terms of the global pattern, Swiss companies are leading in peptide production, while China is the main supplier of GLP-1 active pharmaceutical ingredients.
Shanghai supports the use of AI technology in drug research and development, and continues to increase its support for the development of innovative drugs.
On July 30, the Shanghai Municipal People's Government Office issued several opinions on supporting the innovative development of the entire biomedical industry chain.
Hong Kong stock concept tracking | Diabetes prevention and control action plan released, significant progress has been made in the innovative drug research and development of these enterprises (with concept stocks).
According to Frost & Sullivan data, the scale of China's diabetes medication market is expected to reach 167.5 billion yuan by 2030.
China Securities Co., Ltd.: Q2 albumin batch issuance is the same as last year, and hepatitis B batch issuance has resumed growth.
The blood product industry is expected to maintain steady growth in the first half of 24H1. In the second half of the year, the industry is expected to continue the tight supply and demand pattern. The leading companies in the industry are expected to achieve continuous increase in plasma collection and profitability, and have more competitive advantages.
ChinareS Pharma (03320.HK) has entered into a property leasing and property management services agreement with Chinare Holdings.
On July 23, Gelunhui announced that on July 23, 2024, the company and Chinares Group signed a property leasing and property management services framework agreement. According to this, Chinares Group will provide leasing properties and/or multiple property management services to the Group, with a period from July 23, 2024 to December 31, 2025.
No Data